• Safety & Recalls
  • Regulatory Updates
  • Drug Coverage
  • COPD
  • Cardiovascular
  • Obstetrics-Gynecology & Women's Health
  • Ophthalmology
  • Clinical Pharmacology
  • Pediatrics
  • Urology
  • Pharmacy
  • Idiopathic Pulmonary Fibrosis
  • Diabetes and Endocrinology
  • Allergy, Immunology, and ENT
  • Musculoskeletal/Rheumatology
  • Respiratory
  • Psychiatry and Behavioral Health
  • Dermatology
  • Oncology

First-time generic approvals

Article

Methscopolamine tablets, 2.5 mg (equiv to Pamine tablets)

Methscopolamine tablets, 2.5 mg (equiv to Pamine tablets)
BOCA PHARMACAL

Methscopolamine tablets, 5 mg (equiv to Pamine Forte tablets)
BOCA PHARMACAL

Bupropion extended-release tablets, 150 and 300 mg (equiv to Wellbutrin XL extended-release tablets)
ANCHEN

Ondansetron orally disintegrating tablets, 4, 8, 16, and 24 mg (equiv to Zofran orally disintegrating tablets)
KALI

Ondansetron oral solution, 4 mg (base)/5 mL (equiv to Zofran oral solution)
ROXANE

Albuterol and ipratropium inhalation solution, 3 mg (0.083%) and 0.5 mg (0.017%) in 3-mL vials (equiv to DuoNeb inhalation solution)
SANDOZ

Related Content
© 2024 MJH Life Sciences

All rights reserved.